Julie K. Casteel, serving as the Chief Sales/Marketing Officer at IBEX Ltd (NASDAQ: IBEX), executed a transaction involving the sale of 3,600 common shares on June 11, 2026. The total value derived from this sale was $110,183. The shares were disposed of at prices fluctuating between $30.465 and $30.78 per share, resulting in a weighted average sale price of $30.6065. Following the completion of this transaction, Ms. Casteel maintains a direct ownership position of 117,594 common shares in IBEX.
The insider sale activity is documented in a Form 4 filing submitted to the U.S. Securities and Exchange Commission on June 16, 2026. The filing was executed and signed by Lisa Lenstrohm acting in the capacity of Attorney-in-Fact.
Market valuation metrics indicate that IBEX is currently trading at a price-to-earnings (P/E) ratio of 9.71. This valuation is characterized as low when measured against the company's near-term earnings growth trajectory. Independent analysis from InvestingPro suggests that the stock's current pricing may indicate undervaluation relative to its fair value assessment, positioning it among potential opportunities within the broader market.
This financial reporting period coincides with IBEX Ltd announcing its third-quarter fiscal 2026 results. The company reported revenue reaching $164.4 million, which surpassed the consensus expectation of $155.86 million by a margin of 5.48%. The company's earnings per share were recorded at $0.91, a figure that aligned precisely with analyst projections.
In conjunction with these earnings, IBEX announced the authorization of a new share repurchase program by its Board of Directors. This program permits the company to repurchase up to $20 million of its common stock over the subsequent twelve-month period. The capital for these repurchases will be sourced from existing cash reserves and free cash flow. These strategic financial decisions reflect the company's approach to financial management and its stated commitment to returning value to shareholders.